NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NCEL NewcelX Ltd.

未开盘 03-09 16:00:00 EDT

2.74

-0.03

-1.08%

盘后2.69

-0.05-1.70%

17:22 EDT

最高3.08	最低2.66	成交量12.61万
今开2.97	昨收2.77	日振幅15.16%
总市值1,249万	流通市值1,249万	总股本455.84万
成交额36.47万	换手率2.77%	流通股本455.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NCEL","market":"US","secType":"STK","nameCN":"NewcelX Ltd.","latestPrice":2.74,"timestamp":1773086400000,"preClose":2.77,"halted":0,"volume":126108,"hourTrading":{"tag":"盘后","latestPrice":2.6934,"preClose":2.74,"latestTime":"17:22 EDT","volume":6415,"amount":17445.0112,"timestamp":1773091356535,"change":-0.0466,"changeRate":-0.017007,"amplitude":0.017007},"delay":0,"changeRate":-0.010830324909747223,"floatShares":4558400,"shares":4558400,"eps":-4.322621,"marketStatus":"未开盘","change":-0.03,"latestTime":"03-09 16:00:00 EDT","open":2.97,"high":3.08,"low":2.66,"amount":364699.2160152,"amplitude":0.151625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.322621,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773129600000},"marketStatusCode":0,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":2.77,"preHourTrading":{"tag":"盘前","latestPrice":2.98,"preClose":2.77,"latestTime":"09:20 EDT","volume":6049,"amount":17906.116722,"timestamp":1773062412085,"change":0.21,"changeRate":0.075812,"amplitude":0.115523},"postHourTrading":{"tag":"盘后","latestPrice":2.6934,"preClose":2.74,"latestTime":"17:22 EDT","volume":6415,"amount":17445.0112,"timestamp":1773091356535,"change":-0.0466,"changeRate":-0.017007,"amplitude":0.017007},"volumeRatio":24.323574},"requestUrl":"/m/hq/s/NCEL/wiki","defaultTab":"wiki","newsList":[{"id":"2614773552","title":"Newcelx Ltd.盘中异动 早盘急速拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614773552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614773552?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:57","pubTimestamp":1771945028,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时57分，Newcelx Ltd.股票出现异动，股价快速拉升5.48%。截至发稿，该股报2.79美元/股，成交量332股，换手率0.01%，振幅0.00%。Newcelx Ltd.股票所在的生物技术行业中，整体涨幅为0.37%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224225708a71a63e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224225708a71a63e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"2609517287","title":"Newcelx Ltd.盘中异动 临近收盘股价大涨5.11%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609517287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609517287?lang=zh_cn&edition=full","pubTime":"2026-02-07 04:36","pubTimestamp":1770410218,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日04时36分，Newcelx Ltd.股票出现波动，股价大幅上涨5.11%。截至发稿，该股报2.78美元/股，成交量9751股，换手率0.21%，振幅4.55%。Newcelx Ltd.股票所在的生物技术行业中，整体涨幅为1.43%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207043659a485e10a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207043659a485e10a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"2605450954","title":"Newcelx Ltd.盘中异动 股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605450954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605450954?lang=zh_cn&edition=full","pubTime":"2026-01-23 00:45","pubTimestamp":1769100344,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日00时45分，Newcelx Ltd.股票出现波动，股价急速拉升6.31%。截至发稿，该股报2.57美元/股，成交量3.0889万股，换手率0.68%，振幅5.37%。Newcelx Ltd.股票所在的生物技术行业中，整体涨幅为0.90%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123004544953df42f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123004544953df42f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCEL","BK4139"],"gpt_icon":0},{"id":"2605787451","title":"Newcelx Ltd.盘中异动 早盘股价大涨5.93%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605787451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605787451?lang=zh_cn&edition=full","pubTime":"2026-01-21 00:01","pubTimestamp":1768924914,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日00时01分，Newcelx Ltd.股票出现波动，股价急速上涨5.93%。截至发稿，该股报2.50美元/股，成交量3.5072万股，换手率0.77%，振幅4.66%。Newcelx Ltd.股票所在的生物技术行业中，整体跌幅为0.62%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121000155a7314055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121000155a7314055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"2603642466","title":"Newcelx Ltd.盘中异动 早盘股价大涨5.26%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603642466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603642466?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:06","pubTimestamp":1768403216,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时06分，Newcelx Ltd.股票出现波动，股价快速拉升5.26%。截至发稿，该股报2.60美元/股，成交量2.2568万股，换手率0.50%，振幅9.24%。Newcelx Ltd.股票所在的生物技术行业中，整体跌幅为0.16%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011423065697a1d39c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011423065697a1d39c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCEL","BK4139"],"gpt_icon":0},{"id":"2601742898","title":"Newcelx Ltd.盘中异动涨7.75% 振幅达22.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601742898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601742898?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:36","pubTimestamp":1767623778,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时36分，Newcelx Ltd.股票出现波动，股价大幅上涨7.75%。截至发稿，该股报2.25美元/股，成交量47.5385万股，换手率10.43%，振幅22.01%。Newcelx Ltd.股票所在的生物技术行业中，整体跌幅为0.58%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010522361897a10d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010522361897a10d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"1122151526","title":"NewcelX任命瑞士糖尿病创新巨头Julien Boisdron博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1122151526","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122151526?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:07","pubTimestamp":1767614836,"startTime":"0","endTime":"0","summary":"NewcelX Ltd.宣布，瑞士糖尿病创新领域的领军人物Julien Boisdron博士已正式加入其科学顾问委员会。这一重要人事任命将显著增强公司在糖尿病治疗领域的研发实力。Boisdron博士在大型制药企业积累的丰富经验，有望为NewcelX的技术创新和战略发展注入新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"2595874370","title":"Newcelx Ltd.盘中异动 早盘股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595874370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595874370?lang=zh_cn&edition=full","pubTime":"2025-12-31 00:09","pubTimestamp":1767110949,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日00时09分，Newcelx Ltd.股票出现异动，股价大幅下跌5.14%。截至发稿，该股报2.03美元/股，成交量2.3783万股，换手率0.52%，振幅3.97%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Newcelx Ltd.股票所在的生物技术行业中，整体跌幅为0.78%。Newcelx Ltd.公司简介：NewcelX Ltd 是一家生物技术公司，开发用于治疗神经退行性疾病和代谢性疾病的变革性细胞疗法和小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231000910953bd57a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231000910953bd57a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCEL","BK4139"],"gpt_icon":0},{"id":"1143544598","title":"NewcelX有限公司通过任命Barrow神经科学研究所首席医疗官Jeremy Shefner博士增强科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1143544598","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143544598?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:02","pubTimestamp":1763380947,"startTime":"0","endTime":"0","summary":"NewcelX有限公司通过任命Barrow神经科学研究所首席医疗官Jeremy Shefner博士增强科学顾问委员会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"1199796406","title":"NewcelX 在与 NLS Pharmaceutics Ltd. 合并后提供业务和战略路线图更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1199796406","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199796406?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:27","pubTimestamp":1762176430,"startTime":"0","endTime":"0","summary":"NewcelX 在与 NLS Pharmaceutics Ltd. 合并后提供业务和战略路线图更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4139"],"gpt_icon":0},{"id":"1166589130","title":"NLS Pharmaceutics：在与Kadimastem合并后，合并公司将继续推进Itol-102项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1166589130","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166589130?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:22","pubTimestamp":1761736977,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics：在与Kadimastem合并后，合并公司将继续推进Itol-102项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007","NCEL"],"gpt_icon":0},{"id":"1171878787","title":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称，以配合与Kadimastem的拟议合并","url":"https://stock-news.laohu8.com/highlight/detail?id=1171878787","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171878787?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:00","pubTimestamp":1761732022,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称，以配合与Kadimastem的拟议合并。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","NLSPW","BK4007","NLSP"],"gpt_icon":0},{"id":"1176769345","title":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成以及Kadimastem股票的退市日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1176769345","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176769345?lang=zh_cn&edition=full","pubTime":"2025-10-29 15:54","pubTimestamp":1761724465,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成，并确认Kadimastem股票的退市日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007","NCEL"],"gpt_icon":0},{"id":"1131118792","title":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作，以推动下一代基因编辑细胞疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1131118792","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131118792?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:02","pubTimestamp":1761562934,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作，以推动下一代基因编辑细胞疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSPW","NLSP","NCEL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nlspharma.com","stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.0108},{"period":"3month","weight":-0.3978},{"period":"6month","weight":-0.8676},{"period":"1year","weight":-0.8388},{"period":"ytd","weight":0.4421}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NewcelX Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司，致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.029374},{"month":2,"riseRate":0.5,"avgChangeRate":0.017842},{"month":3,"riseRate":0.5,"avgChangeRate":-0.01541},{"month":4,"riseRate":0,"avgChangeRate":-0.175846},{"month":5,"riseRate":0.4,"avgChangeRate":0.007372},{"month":6,"riseRate":0.6,"avgChangeRate":0.133578},{"month":7,"riseRate":0.2,"avgChangeRate":-0.210549},{"month":8,"riseRate":0.6,"avgChangeRate":0.043884},{"month":9,"riseRate":0.4,"avgChangeRate":-0.067099},{"month":10,"riseRate":0,"avgChangeRate":-0.247213},{"month":11,"riseRate":0.2,"avgChangeRate":-0.070852},{"month":12,"riseRate":0.4,"avgChangeRate":-0.07921}],"exchange":"NASDAQ","name":"NewcelX Ltd.","nameEN":"NewcelX Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NewcelX Ltd.(NCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NewcelX Ltd.,NCEL,NewcelX Ltd.股票,NewcelX Ltd.股票老虎,NewcelX Ltd.股票老虎国际,NewcelX Ltd.行情,NewcelX Ltd.股票行情,NewcelX Ltd.股价,NewcelX Ltd.股市,NewcelX Ltd.股票价格,NewcelX Ltd.股票交易,NewcelX Ltd.股票购买,NewcelX Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NewcelX Ltd.(NCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}